Recruiting Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass NCT07272837 Conditions Body Weight, Diabetes, Diabetes Mellitus, +14 more Locations Mazankowski Alberta Heart Institute — Edmonton, Alberta, Canada View Trial Details
Recruiting The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes NCT07272343 Conditions Caloric Restriction, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more Locations Minde road No.1 — Jiangxi, Nanchang, China View Trial Details
Recruiting Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance NCT06856291 Conditions Body Weight, Body Weight Changes, Glucose Metabolism Disorders, +15 more Locations Cantonal Hospital Aarau — Aarau, Canton of Aargau, Switzerland View Trial Details
Not Yet Recruiting Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth NCT06934655 Conditions Body Weight, Metabolic and Bariatric Surgery, Nutrition Disorders, +8 more Locations Children's Hospital Los Angeles — Los Angeles, California, United States View Trial Details
Not Yet Recruiting Semaglutide Treatment in Type 1 Diabetes NCT06909006 Conditions Autoimmune Diseases, Body Weight, Body Weight Changes, +24 more Locations Nordsjaellands Hospital — Hillerød, Denmark View Trial Details
Completed The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity NCT04263415 Conditions Central Neural Response, Dysgeusia, Gastric Emptying, +10 more Locations UMC Ljubljana — Ljubljana, Slovenia View Trial Details
